Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:37:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:35:08.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:51:20.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 and the prior Revision: v3.4.1 notice has been removed; the change is metadata-related and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:53:45.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a government funding notice at the top of the page indicating possible updates and current operating status, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T22:46:52.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a glossary toggle and QC/versioning metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0); removed older QC wording (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T17:45:04.000Z thumbnail image

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.